Jaquavian L. Devol of Wellington pleaded guilty to abandoning an animal, resulting in probation and community service, after ...

The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE: PFE) Depo-Provera contraceptive injection, adding a warning about the risk of meningioma, a type of ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

If you took the warning label that comes with your birth control and tossed it right in the trash, you wouldn’t be alone. After all, every medication comes with a risk of side effects, and those ...

Here we go again. Sean “Diddy” Combs is preparing to give a videotaped deposition from federal prison as part of an ongoing civil lawsuit filed by April Lampros, adding another layer to the music ...

The label revision follows emerging evidence linking long-term use of Depo-Provera (medroxyprogesterone acetate) to a higher likelihood of developing meningiomas — tumors that, while often benign, can ...

Have you seen an adorable exotic pet in a TikTok recently? Before you bring that hedgehog home, here's what to know.

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a ...

Judge in Depo-Provera MDL Orders Additional Briefing on FDA's Brain Tumor Warning At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental ...

The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...